ヒガンバナ科アルカロイド, リコリン及びリコリシジノールによる炎症性サイトカイン, TNF-α産生の阻害

DOI Web Site Web Site PubMed 被引用文献1件 参考文献17件 オープンアクセス

書誌事項

タイトル別名
  • Inhibition Effect of Amaryllidaceae Alkaloids, Lycorine and Lycoricidinol on Macrophage TNF-α Production
  • ヒガンバナカ アルカロイド リコリン オヨビ リコリシジノール ニ ヨル エンショウセイ サイトカイン TNF アルファ サンセイ ノ ソガイ

この論文をさがす

説明

We previously demonstrated that Amaryllidaceae alkaloids, lycorine and lycoricidinol, inhibit induction of apoptosis by calprotectin derived from neutrophils, and that the latter alkaloid showed suppression in rat adjuvant-induced arthritis model. These findings suggest that the alkaloids have a modulating activity against inflammatory reaction. To explore further the mechanism of the suppression for inflammation, we studied the effect of the alkaloids on macrophage tumor necrosis factor (TNF-α) production in vitro, since TNF-α is recognized as a pivotal cytokine to regulate inflammation. As a result of this study, lycorine and lycoricidinol inhibited TNF-α production of murine macrophages stimulated with lipopolysaccharide (ID50 were 0.2 μg/ml and 0.002 μg/ml, respectively). The inhibition was also observed in macrophages treated by Gram-positive bacteria, Enterococcus faecalis. Both lycorine and lycoricidinol reportedly have inhibitory activity for protein biosynthesis. Although the inhibition of TNF-α production by lycoricidinol was mainly due to the inhibition of protein biosynthesis, lycorine showed inhibition against TNF-α production at lower concentrations than the case that they inhibited 35S-Cysteine/35S-Methionine incorporation into macrophages. These facts sugges that the inhibition of TNF-α production is not due to the inhibitory activity against protein translation at least at lower concentrations. From these results, it was concluded that these alkaloids exert inhibitory effects not only on neutrophil apoptosis-inducing protein, calprotectin, but also on macrophage TNF-α production.

収録刊行物

  • 薬学雑誌

    薬学雑誌 121 (2), 167-171, 2001-02-01

    公益社団法人 日本薬学会

被引用文献 (1)*注記

もっと見る

参考文献 (17)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ